The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

NCT04805801 · clinicaltrials.gov ↗

UNKNOWN

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A With Inhibitor
Hemophilia A Without Inhibitor

Interventions

DRUG: Emicizumab subcutaneous injection

Sponsor

JW Pharmaceutical